ストックスクリーナーアプリを入手
2.18
0.93%
0.02
アフターアワーズ：
2.18
Biomerica Inc (BMRA) 最新ニュース
Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026 - Weekly Voice
An IBS diet-guided therapy gets a slot at the world's biggest GI meeting - Stock Titan
BMRA Stock Price, Quote & Chart | BIOMERICA INC (NASDAQ:BMRA) - ChartMill
BMRA (Biomerica Inc.) slips 0.91% following Q1 2026 earnings release with no available analyst consensus estimates.Hedge Fund Inspired Picks - Xã Thanh Hà
BMRA (Biomerica Inc.) posts 1.9 percent year-over-year Q1 2026 revenue dip, shares gain 4.27 percent. - Xã Vĩnh Công
Biomerica Q3 Sales Fall, Net Loss Widens Amid Restructuring - Orange County Business Journal
Biomerica (BMRA) Secures Medicare Coverage for inFoods IBS Tests - GuruFocus
Biomerica, Inc. Receives Medicare Confirmation for inFoods® IBS Claims Processing Pathway - Quiver Quantitative
Biomerica Inc Announces Medicare Administrative Contractor Confirmation of Individual Claim Review For Infoods Ibs Test - marketscreener.com
Medicare can now review claims for Biomerica's $300 IBS test - Stock Titan
Biomerica (BMRA) Stock Bonus Issue (Investor Interest) 2026-04-15Trader Community Insights - Cổng thông tin điện tử Tỉnh Sơn La
Biomerica, Inc., Phoenix Airmid Biomedical And CanAlt Health Labs Launch inFoods IBS Platform In Canada - marketscreener.com
Biomerica reports net loss of USD 1.31M in Q3 2026 - Medical Buyer
Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs - The Manila Times
Up to 5 million Canadians have IBS; Biomerica brings inFoods north - Stock Titan
Biomerica's Q3 revenue falls, net loss widens on lower manufacturing sales - TradingView
Biomerica Reports Third Quarter Fiscal 2026 Financial Results - Weekly Voice
Biomerica Reports Third Quarter Fiscal 2026 Financial Results, Highlights Real-World Efficacy of inFoods® IBS and Growth in European Revenue - Quiver Quantitative
BRIEF-Biomerica Q3 Net Income USD -1.31 Million - TradingView
Press Release: Biomerica Reports Third Quarter Fiscal 2026 Financial Results - Moomoo
Biomerica 10-Q: Revenue $0.99M, EPS $(0.44) for Q3 ended Feb 28, 2026 - TradingView
Biomerica (BMRA) revenue falls 22% as losses persist and going concern risk disclosed - Stock Titan
Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 - marketscreener.com
Update Report: Will Biomerica Inc stock benefit from M A2026 Earnings Impact & Weekly Stock Breakout Alerts - baoquankhu1.vn
Aug Breakouts: Is Biomerica Inc a strong candidate for buy and holdMarket Volume Summary & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Press Releases about Biomerica, Inc.Common Stock (Nasdaq:BMRA) - FinancialContent
How does Biomerica (BMRA) Stock compare to competitors | Price at $2.16, Up 0.47%Institutional Flow - Cổng thông tin điện tử Tỉnh Sơn La
Biomerica (BMRA) to Post Earnings on Monday - Defense World
BMRA: BiomericaInteractive Chart - Zacks Investment Research
Is Biomerica (BMRA) Stock Moving Sideways | Price at $2.17, Down 0.91%Community Momentum Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Should value investors consider Biomerica Inc2026 Price Targets & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
AI Stocks: Whats the fair value of Biomerica Inc stockMarket Risk Report & Fast Gain Swing Alerts - baoquankhu1.vn
Rate Hike: What is the PEG ratio of Biomerica Inc2026 EndofYear Setup & Stock Portfolio Risk Management - baoquankhu1.vn
BMRA PE Ratio & Valuation, Is BMRA Overvalued - intellectia.ai
Biomerica gets first commercial order for H pylori test - MSN
Biomerica Receives First Commercial Order for its H. pylori test from one of the Largest Clinical Laboratory Chains in Europe - marketscreener.com
Biomerica (BMRA) Secures First European Order for H. pylori Test - GuruFocus
First European commercial order landed: US diagnostic product company Biomerica announces that its Helicobacter pylori detection product HP Detect™ has received the first commercial order from one of Europe's largest clinical laboratory chains. - Bitget
Biomerica Secures First Commercial Order for Hp Detect™ from Major European Laboratory Chain - Quiver Quantitative
Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect) from One of the Largest Clinical Laboratory Chains in Europe - Bitget
Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe - marketscreener.com
Stomach cancer bacteria drives major lab’s first order of Hp Detect test - Stock Titan
Earnings Miss: Is Biomerica Inc stock a value trap2025 Top Decliners & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Biomerica receives UK regulatory approval for H. pylori test - Investing.com
Biomerica receives UK regulatory approval for H. pylori test By Investing.com - Investing.com Nigeria
Biomerica (BMRA) Expands Market with UK Approval for hp+detect T - GuruFocus
Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain - The Manila Times
Portfolio Recap: How does PSHG score in quality rankingsJuly 2025 Review & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Market Review: Can Biomerica Inc stock double in the next yearLayoff News & Weekly High Conviction Ideas - baoquankhu1.vn
Biomerica reports real-world IBS test results, Medicare rate set - Investing.com
Biometrica Down on Study - Baystreet.ca
Biomerica reports real-world IBS test results, Medicare rate set By Investing.com - Investing.com South Africa
Biomerica, Inc. Reports Successful Responder Analysis Results for inFoods® IBS and Establishes $300 Medicare Payment Rate - Quiver Quantitative
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy - Weekly Voice
New finger-stick IBS test eases pain and bloating for most patients - Stock Titan
BMRA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Why Innovative Eyewear, Inc. stock attracts strong analyst attention - baoquankhu1.vn
BMRA Should I Buy - Intellectia AI
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods IBS Therapy - Bitget
Biomerica (NASDAQ:BMRA) Stock Passes Below 200 Day Moving Average – Here’s Why - Defense World
Will Biomerica Inc. stock rally after Fed decisions2025 Technical Patterns & Weekly Breakout Stock Alerts - mfd.ru
Biomerica Gains Regulatory Approval for At-Home Cancer Test in Vietnam - AD HOC NEWS
Midday Stock Roundup: Biomerica Rises 4.7% on Medicare Coverage - Orange County Business Journal
2.95%
大文字化:
|
ボリューム (24 時間):